HURN (HURN) Stock Analysis

Verdict: BUY

Record earnings beats and a major 2026 guidance raise propel HURN, but aggressive insider selling and a high debt load cap the upside.

Investment score: 74/100

Huron is demonstrating strong operational leverage in its Healthcare and Education segments, evidenced by a 4-quarter streak of earnings beats and a significant guidance upgrade for 2026. Despite a 50% weekly move, the forward valuation remains reasonable compared to high-growth peers like EXPO and INOD.

Peers

PeerP/EP/BP/SEV/EBITDAROIC %Net margin %
KBR10.352.670.5611.260.05
AMTM36.221.150.379.160.01
EXPO39.3710.9110.6326.540.28
CBZ26.561.791.077.400.04
INOD48.8415.286.9232.500.14

View the full interactive analysis